Clinical Trial Update: Ph Ib/BGJ398/Cervix and Other Solid Tumors [Phase 1]

View source ↗

Summary

A Phase Ib trial of BGJ398 in cervical cancer and other solid tumors was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Solid Tumors

Drugs mentioned

• BGJ398 (BGJ398)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Cancer of Cervix, Tumors | Phase 1 | Status: WITHDRAWN